SCHEMBL6909235

SCHEMBL6909235

COc1cc(C(F)(F)F)cc(OC(F)F)c1C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
CYP3A4 P08684 2/20 0.41
MAPK1 P28482 2/20 0.41
USP2 O75604 2/20 0.41
AKR1C3 P42330 2/20 0.39
AKR1C2 P52895 2/20 0.39
KMT2A Q03164 2/20 0.38
LMNA P02545 2/20 0.37
HTT P42858 2/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 2/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL421296 0.88 CA12 (0.42) SMN1; SMN2USP2AKR1C3AKR1C2KMT2A
SCHEMBL425506 0.87 NOTUM (0.43) SMN1; SMN2MAPK1AKR1C3AKR1C2KMT2A
SCHEMBL7888228 0.76 SLC6A9 (0.47) CYP2C19SLC6A9
SCHEMBL421721 0.75 CA12 (0.52) MAPK1USP2AKR1C3AKR1C2LMNA
SCHEMBL423901 0.74 GPR35 (0.41) CYP3A4USP2AKR1C3AKR1C2MAPT
SCHEMBL14817465 0.74 NOTUM (0.51) AKR1C3AKR1C2KMT2ALMNAMEN1
SCHEMBL9724303 0.73 CYP3A4 (0.50) SMN1; SMN2CYP3A4MAPK1USP2KMT2A
SCHEMBL1105439 0.71 HPGD (0.43) CYP3A4USP2AKR1C3AKR1C2KMT2A
SCHEMBL30951357 0.71 HPGD (0.43) CYP3A4USP2AKR1C3AKR1C2KMT2A
SCHEMBL10153576 0.70 NOTUM (0.47) CYP3A4HPGDNOTUMSLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011023667-A1 CARBOCYCLIC GLYT1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-03-03 WO disclosed